CICALESE, MARIA PIA
 Distribuzione geografica
Continente #
AS - Asia 2.058
NA - Nord America 1.598
EU - Europa 1.109
SA - Sud America 528
AF - Africa 60
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.369
Nazione #
US - Stati Uniti d'America 1.512
SG - Singapore 847
CN - Cina 640
BR - Brasile 438
SE - Svezia 290
IT - Italia 269
HK - Hong Kong 243
VN - Vietnam 133
DE - Germania 129
RU - Federazione Russa 100
GB - Regno Unito 87
IN - India 56
CA - Canada 51
AT - Austria 43
PL - Polonia 33
AR - Argentina 32
FI - Finlandia 31
JP - Giappone 30
MX - Messico 28
NL - Olanda 28
FR - Francia 26
ZA - Sudafrica 22
ES - Italia 21
EC - Ecuador 17
IQ - Iraq 17
TR - Turchia 17
BD - Bangladesh 14
LT - Lituania 14
CO - Colombia 12
IE - Irlanda 12
UA - Ucraina 12
ID - Indonesia 11
AU - Australia 9
DZ - Algeria 9
IR - Iran 8
IL - Israele 7
PE - Perù 7
UY - Uruguay 7
ET - Etiopia 6
KR - Corea 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
MA - Marocco 5
PY - Paraguay 5
VE - Venezuela 5
BE - Belgio 4
BG - Bulgaria 4
EG - Egitto 4
EU - Europa 4
TN - Tunisia 4
UZ - Uzbekistan 4
CH - Svizzera 2
CL - Cile 2
DO - Repubblica Dominicana 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
NP - Nepal 1
NR - Nauru 1
PK - Pakistan 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SR - Suriname 1
TJ - Tagikistan 1
Totale 5.369
Città #
Singapore 453
Dallas 243
Hong Kong 241
Shanghai 181
Ashburn 171
New York 133
Hefei 101
Beijing 99
Lawrence 78
Milan 78
Princeton 78
Los Angeles 53
São Paulo 53
Ho Chi Minh City 49
Moscow 43
Nuremberg 36
Munich 35
Boardman 33
Rome 32
Warsaw 29
Denver 27
Tokyo 26
Hanoi 25
London 22
Poplar 22
Brooklyn 20
Guangzhou 20
Helsinki 20
Vienna 20
Cesano Boscone 18
Santa Clara 18
Stockholm 18
Chicago 17
Brescia 16
Chennai 16
Toronto 16
Montreal 15
Orem 14
Seattle 14
Ankara 13
Johannesburg 13
Rio de Janeiro 13
Mexico City 12
Phoenix 12
The Dalles 12
Atlanta 11
Frankfurt am Main 11
Houston 11
Pune 11
Shenzhen 11
Amsterdam 10
Hangzhou 10
Dublin 9
Haiphong 9
Monza 9
Belo Horizonte 8
Boston 8
Paris 8
Salvador 8
Brasília 7
Cambridge 7
Curitiba 7
Falkenstein 7
Lima 7
Mumbai 7
Sorocaba 7
Turku 7
Columbus 6
Fortaleza 6
Guayaquil 6
Madrid 6
Manchester 6
Montevideo 6
Turin 6
Washington 6
Aksum 5
Bengaluru 5
Bogotá 5
Brisbane 5
Changsha 5
Charlotte 5
Hillah 5
Philadelphia 5
Porto Alegre 5
Querétaro 5
Raleigh 5
Rishon LeTsiyyon 5
St Petersburg 5
Biên Hòa 4
Calgary 4
Campinas 4
Chevy Chase 4
Council Bluffs 4
Delhi 4
Florence 4
Fremont 4
Hamburg 4
Kassel 4
Lappeenranta 4
Maceió 4
Totale 3.009
Nome #
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 328
Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children 130
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 108
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 103
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 98
Efficacy and safety of an amino-acid-based formula during the period of weaning children with intestinal failure and parenteral nutrition 92
A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation 92
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 91
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 91
Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset 91
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 86
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 82
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 77
Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature 76
A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency 74
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 73
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 72
ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation 72
Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency 72
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease 71
Abnormalities of acid-base balance and predisposition to metabolic acidosis in Metachromatic Leukodystrophy patients 69
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency 69
A Prevalent CXCR3+ Phenotype of Circulating Follicular Helper T Cells Indicates Humoral Dysregulation in Children with Down Syndrome 67
Correction to: A Case of Two Adult Brothers with Wiskott‑Aldrich Syndrome, One Treated with Gene Therapy and One with HLA‑Identical Hematopoietic Stem Cell Transplantation (Journal of Clinical Immunology, (2022), 42, 2, (421-425), 10.1007/s10875-021-01157-6) 65
Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies 65
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency 65
A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation 65
Reduced Follicular Regulatory T Cells in Spleen and Pancreatic Lymph Nodes of Patients With Type 1 Diabetes 64
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 63
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients 63
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated BCGitis 61
Up to 10.5 Years of Follow-Up in 17 Subjects Treated with Hematopoietic Stem and Progenitor Cell Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome 60
Beta2 integrins are required for follicular helper T cell differentiation in humans 60
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome 57
Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy 56
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report 56
Circulating follicular helper and follicular regulatory T cells are severely compromised in human CD40 deficiency: A case report 55
Clinical, immunological, and molecular features of typical and atypical severe combined immunodeficiency: Report of the italian primary immunodeficiency network 55
Urogenital Abnormalities in Adenosine Deaminase Deficiency 55
Central venous access devices in pediatric malignancies: a position paper of Italian Association of Pediatric Hematology and Oncology 54
Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report 53
Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: Change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response 53
Telemedicine in myocarditis: Evolution of a mutidisciplinary “disease unit” at the time of COVID-19 pandemic 52
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 52
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 52
EFFICACY OF THE ANDRESEN ACTIVATOR BEFORE PEAK GROWTH IN CLASS II PATIENTS 51
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 51
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial 51
Clinical applications of gene therapy for primary immunodeficiencies 50
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency 50
Gene therapy in rare diseases: The benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID 49
Treatment with rapamycin can restore regulatory T-cell function in IPEX patients 49
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 48
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 48
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 47
Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans 47
Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit 46
Immunosuppressive therapy in childhood‐onset arrhythmogenic inflammatory cardiomyopathy 46
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients 46
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 46
Neutrophils drive type-I interferon production and autoantibodies in Wiskott-Aldrich syndrome 43
Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis 43
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy 43
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients (Journal of Clinical Immunology, (2021), 41, 7, (1633-1647), 10.1007/s10875-021-01098-0) 42
Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity 42
In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases 42
Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children 41
Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies 41
Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity 41
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β 41
Editorial: Follicular Helper T Cells in Immunity and Autoimmunity 41
LENTIVIRAL VECTOR TRANSDUCED CD34+CELLS FOR THE TREATMENT OF WISKOTT-ALDRICH SYNDROME 40
NADPH Oxidase Deficiency: A Multisystem Approach 40
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 40
Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD 39
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP) 39
T regulatory cell therapy in preclinical and clinical pancreatic islet transplantation 38
Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy 37
Lentiviral gene therapy corrects platelet phenotype and function in Wiskott-Aldrich patients 37
First occurrence of plasmablastic lymphoma in adenosine deaminase-deficient severe combined immunodeficiency disease patient and review of the literature 37
Risk of seizures in children receiving busulphan-containing regimens for stem cell transplantation 37
Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety 36
New perspectives in gene therapy for inherited disorders 36
Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy 36
Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiency 35
NFKB2 regulates human Tfh and Tfr pool formation and germinal center potential 35
Relationship between severe obesity and gut inflammation in children: what’s next? 34
Requesting iodine supplementation in children on parenteral nutrition 32
Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer 32
SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity 31
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 31
La mucosite post-chemioterapia in bambini sottoposti a terapia genica, l'esperienza del San Raffaele di Milano 29
Gene therapy trial with lentiviral vector transduced CD34+cells for the treatment of Wiskott-Aldrich Syndrome 29
CXCR5-CXCL13 axis markers in full-term and preterm human neonates in the first weeks of life 29
Management of autoimmune hepatitis in children: how many steps away from common agreement? 27
Treatment of chronic hepatitis C in children with pegylated interferon and ribavirin : the impact of dose 26
Intergenerational and intrafamilial phenotypic variability in 22q11.2 deletion syndrome subjects 25
Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunity 20
null 1
Totale 5.558
Categoria #
all - tutte 38.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.477


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 7 3 0 0 1 0 0
2021/202286 0 0 1 13 6 3 8 9 33 4 6 3
2022/2023588 171 113 47 4 11 67 18 56 37 15 27 22
2023/2024604 47 33 59 69 47 100 29 43 5 28 25 119
2024/20251.762 161 42 66 75 76 130 214 227 282 193 120 176
2025/20262.434 347 340 431 733 460 123 0 0 0 0 0 0
Totale 5.558